Real-World Effectiveness and Safety of Nivolumab in Special Subgroups of NSCLC pts: A Multicenter-Retrospective Study

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of oncology 2019-10, Vol.30, p.vi110
Hauptverfasser: Kitazono, Satoru, Morita, Ryo, Okishio, Kyoichi, Shimizu, Junichi, Saito, Haruhiro, Sakai, Hiroshi, Kim, Young Hak, Hataji, Osamu, Yomota, Makiko, Aoe, Keisuke, Kanai, Osamu, Kumagai, Toru, Kibata, Kayoko, Tsukamoto, Hiroaki, Oizumi, Satoshi, Tomii, Keisuke, Tanaka, Hiroshi, Mizuno, Keiko, Hoshiyama, Hirotoshi, Ochi, Kenya, Ohe, Yuichiro
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page vi110
container_title Annals of oncology
container_volume 30
creator Kitazono, Satoru
Morita, Ryo
Okishio, Kyoichi
Shimizu, Junichi
Saito, Haruhiro
Sakai, Hiroshi
Kim, Young Hak
Hataji, Osamu
Yomota, Makiko
Aoe, Keisuke
Kanai, Osamu
Kumagai, Toru
Kibata, Kayoko
Tsukamoto, Hiroaki
Oizumi, Satoshi
Tomii, Keisuke
Tanaka, Hiroshi
Mizuno, Keiko
Hoshiyama, Hirotoshi
Ochi, Kenya
Ohe, Yuichiro
description
doi_str_mv 10.1093/annonc/mdz338.084
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdz338_084</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1093_annonc_mdz338_084</sourcerecordid><originalsourceid>FETCH-LOGICAL-c854-207427123608f0d77720daab0e5ce5a97f179661d7ab194625c62b804dda4223</originalsourceid><addsrcrecordid>eNot0MtKw0AYBeBZKFirD-BuXiDtP5dkMu5KqBeoCo3gMkzmIpF0EmYmhfr0VuPqbA7nwIfQHYEVAcnWyvvB6_XBfDNWrqDkF2gBkrJM5IxfoesYvwCgkFQu0LS3qs8-htAbvHXO6tQdrbcxYuUNrpWz6YQHh1-749BPB9XizuN6tLpTPa6n9jMM0xj_GnW1q_CY4j3e4JepT522PtmQ7W0KQxznaVynyZxu0KVTfbS3_7lE9cP2vXrKdm-Pz9Vml-ky5xkFwakglBVQOjBCCApGqRZsrm2upHBEyKIgRqiWSF7QXBe0LYEbozilbInIvKrP_zFY14yhO6hwagg0v1LNLNXMUs1Ziv0A1cJhsQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Real-World Effectiveness and Safety of Nivolumab in Special Subgroups of NSCLC pts: A Multicenter-Retrospective Study</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Kitazono, Satoru ; Morita, Ryo ; Okishio, Kyoichi ; Shimizu, Junichi ; Saito, Haruhiro ; Sakai, Hiroshi ; Kim, Young Hak ; Hataji, Osamu ; Yomota, Makiko ; Aoe, Keisuke ; Kanai, Osamu ; Kumagai, Toru ; Kibata, Kayoko ; Tsukamoto, Hiroaki ; Oizumi, Satoshi ; Tomii, Keisuke ; Tanaka, Hiroshi ; Mizuno, Keiko ; Hoshiyama, Hirotoshi ; Ochi, Kenya ; Ohe, Yuichiro</creator><creatorcontrib>Kitazono, Satoru ; Morita, Ryo ; Okishio, Kyoichi ; Shimizu, Junichi ; Saito, Haruhiro ; Sakai, Hiroshi ; Kim, Young Hak ; Hataji, Osamu ; Yomota, Makiko ; Aoe, Keisuke ; Kanai, Osamu ; Kumagai, Toru ; Kibata, Kayoko ; Tsukamoto, Hiroaki ; Oizumi, Satoshi ; Tomii, Keisuke ; Tanaka, Hiroshi ; Mizuno, Keiko ; Hoshiyama, Hirotoshi ; Ochi, Kenya ; Ohe, Yuichiro</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>DOI: 10.1093/annonc/mdz338.084</identifier><language>eng</language><ispartof>Annals of oncology, 2019-10, Vol.30, p.vi110</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Kitazono, Satoru</creatorcontrib><creatorcontrib>Morita, Ryo</creatorcontrib><creatorcontrib>Okishio, Kyoichi</creatorcontrib><creatorcontrib>Shimizu, Junichi</creatorcontrib><creatorcontrib>Saito, Haruhiro</creatorcontrib><creatorcontrib>Sakai, Hiroshi</creatorcontrib><creatorcontrib>Kim, Young Hak</creatorcontrib><creatorcontrib>Hataji, Osamu</creatorcontrib><creatorcontrib>Yomota, Makiko</creatorcontrib><creatorcontrib>Aoe, Keisuke</creatorcontrib><creatorcontrib>Kanai, Osamu</creatorcontrib><creatorcontrib>Kumagai, Toru</creatorcontrib><creatorcontrib>Kibata, Kayoko</creatorcontrib><creatorcontrib>Tsukamoto, Hiroaki</creatorcontrib><creatorcontrib>Oizumi, Satoshi</creatorcontrib><creatorcontrib>Tomii, Keisuke</creatorcontrib><creatorcontrib>Tanaka, Hiroshi</creatorcontrib><creatorcontrib>Mizuno, Keiko</creatorcontrib><creatorcontrib>Hoshiyama, Hirotoshi</creatorcontrib><creatorcontrib>Ochi, Kenya</creatorcontrib><creatorcontrib>Ohe, Yuichiro</creatorcontrib><title>Real-World Effectiveness and Safety of Nivolumab in Special Subgroups of NSCLC pts: A Multicenter-Retrospective Study</title><title>Annals of oncology</title><issn>0923-7534</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNot0MtKw0AYBeBZKFirD-BuXiDtP5dkMu5KqBeoCo3gMkzmIpF0EmYmhfr0VuPqbA7nwIfQHYEVAcnWyvvB6_XBfDNWrqDkF2gBkrJM5IxfoesYvwCgkFQu0LS3qs8-htAbvHXO6tQdrbcxYuUNrpWz6YQHh1-749BPB9XizuN6tLpTPa6n9jMM0xj_GnW1q_CY4j3e4JepT522PtmQ7W0KQxznaVynyZxu0KVTfbS3_7lE9cP2vXrKdm-Pz9Vml-ky5xkFwakglBVQOjBCCApGqRZsrm2upHBEyKIgRqiWSF7QXBe0LYEbozilbInIvKrP_zFY14yhO6hwagg0v1LNLNXMUs1Ziv0A1cJhsQ</recordid><startdate>201910</startdate><enddate>201910</enddate><creator>Kitazono, Satoru</creator><creator>Morita, Ryo</creator><creator>Okishio, Kyoichi</creator><creator>Shimizu, Junichi</creator><creator>Saito, Haruhiro</creator><creator>Sakai, Hiroshi</creator><creator>Kim, Young Hak</creator><creator>Hataji, Osamu</creator><creator>Yomota, Makiko</creator><creator>Aoe, Keisuke</creator><creator>Kanai, Osamu</creator><creator>Kumagai, Toru</creator><creator>Kibata, Kayoko</creator><creator>Tsukamoto, Hiroaki</creator><creator>Oizumi, Satoshi</creator><creator>Tomii, Keisuke</creator><creator>Tanaka, Hiroshi</creator><creator>Mizuno, Keiko</creator><creator>Hoshiyama, Hirotoshi</creator><creator>Ochi, Kenya</creator><creator>Ohe, Yuichiro</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201910</creationdate><title>Real-World Effectiveness and Safety of Nivolumab in Special Subgroups of NSCLC pts: A Multicenter-Retrospective Study</title><author>Kitazono, Satoru ; Morita, Ryo ; Okishio, Kyoichi ; Shimizu, Junichi ; Saito, Haruhiro ; Sakai, Hiroshi ; Kim, Young Hak ; Hataji, Osamu ; Yomota, Makiko ; Aoe, Keisuke ; Kanai, Osamu ; Kumagai, Toru ; Kibata, Kayoko ; Tsukamoto, Hiroaki ; Oizumi, Satoshi ; Tomii, Keisuke ; Tanaka, Hiroshi ; Mizuno, Keiko ; Hoshiyama, Hirotoshi ; Ochi, Kenya ; Ohe, Yuichiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c854-207427123608f0d77720daab0e5ce5a97f179661d7ab194625c62b804dda4223</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kitazono, Satoru</creatorcontrib><creatorcontrib>Morita, Ryo</creatorcontrib><creatorcontrib>Okishio, Kyoichi</creatorcontrib><creatorcontrib>Shimizu, Junichi</creatorcontrib><creatorcontrib>Saito, Haruhiro</creatorcontrib><creatorcontrib>Sakai, Hiroshi</creatorcontrib><creatorcontrib>Kim, Young Hak</creatorcontrib><creatorcontrib>Hataji, Osamu</creatorcontrib><creatorcontrib>Yomota, Makiko</creatorcontrib><creatorcontrib>Aoe, Keisuke</creatorcontrib><creatorcontrib>Kanai, Osamu</creatorcontrib><creatorcontrib>Kumagai, Toru</creatorcontrib><creatorcontrib>Kibata, Kayoko</creatorcontrib><creatorcontrib>Tsukamoto, Hiroaki</creatorcontrib><creatorcontrib>Oizumi, Satoshi</creatorcontrib><creatorcontrib>Tomii, Keisuke</creatorcontrib><creatorcontrib>Tanaka, Hiroshi</creatorcontrib><creatorcontrib>Mizuno, Keiko</creatorcontrib><creatorcontrib>Hoshiyama, Hirotoshi</creatorcontrib><creatorcontrib>Ochi, Kenya</creatorcontrib><creatorcontrib>Ohe, Yuichiro</creatorcontrib><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kitazono, Satoru</au><au>Morita, Ryo</au><au>Okishio, Kyoichi</au><au>Shimizu, Junichi</au><au>Saito, Haruhiro</au><au>Sakai, Hiroshi</au><au>Kim, Young Hak</au><au>Hataji, Osamu</au><au>Yomota, Makiko</au><au>Aoe, Keisuke</au><au>Kanai, Osamu</au><au>Kumagai, Toru</au><au>Kibata, Kayoko</au><au>Tsukamoto, Hiroaki</au><au>Oizumi, Satoshi</au><au>Tomii, Keisuke</au><au>Tanaka, Hiroshi</au><au>Mizuno, Keiko</au><au>Hoshiyama, Hirotoshi</au><au>Ochi, Kenya</au><au>Ohe, Yuichiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Real-World Effectiveness and Safety of Nivolumab in Special Subgroups of NSCLC pts: A Multicenter-Retrospective Study</atitle><jtitle>Annals of oncology</jtitle><date>2019-10</date><risdate>2019</risdate><volume>30</volume><spage>vi110</spage><pages>vi110-</pages><issn>0923-7534</issn><doi>10.1093/annonc/mdz338.084</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0923-7534
ispartof Annals of oncology, 2019-10, Vol.30, p.vi110
issn 0923-7534
language eng
recordid cdi_crossref_primary_10_1093_annonc_mdz338_084
source EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
title Real-World Effectiveness and Safety of Nivolumab in Special Subgroups of NSCLC pts: A Multicenter-Retrospective Study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T11%3A33%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Real-World%20Effectiveness%20and%20Safety%20of%20Nivolumab%20in%20Special%20Subgroups%20of%20NSCLC%20pts:%20A%20Multicenter-Retrospective%20Study&rft.jtitle=Annals%20of%20oncology&rft.au=Kitazono,%20Satoru&rft.date=2019-10&rft.volume=30&rft.spage=vi110&rft.pages=vi110-&rft.issn=0923-7534&rft_id=info:doi/10.1093/annonc/mdz338.084&rft_dat=%3Ccrossref%3E10_1093_annonc_mdz338_084%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true